BrownEABlakePGBoudvilleN, et al.International Society for Peritoneal Dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int2020; 40: 244–253.
BammensBEvenepoelPVerbekeK, et al.Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int2003; 64: 2238–2243.
4.
ChenCHPerlJTeitelbaumI. Prescribing high-quality peritoneal dialysis: the role of preserving residual kidney function. Perit Dial Int2020; 40: 274–281.
5.
Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol1996; 7: 198–207.
6.
PaniaguaRAmatoDVoneshE, et al.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol2002; 13: 1307–1320.
7.
BargmanJMThorpeKEChurchillDN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol2001; 12: 2158–2162.
8.
ChanEHemmelgarnBKlarenbachS, et al.Choosing Wisely: The Canadian Society of Nephrology's List of 5 Items Physicians and Patients Should Question. Can J Kidney Health Dis2017; 4: 1–9. DOI: 10.1177/2054358117695570.
9.
SandriniMVizzardiVValerioF, et al.Incremental peritoneal dialysis: a 10 year single-centre experience. J Nephrol2016; 29: 871–879.
10.
HtayHChoYPascoeEM, et al.Predictors of residual renal function decline in peritoneal dialysis patients: The balANZ trial. Perit Dial Int2017; 37: 283–289.
11.
LeeYChungSWParkS, et al.Incremental peritoneal dialysis may be beneficial for preserving residual renal function compared to full-dose peritoneal dialysis. Sci Rep2019; 9: 10105.
12.
DaviesSJPhillipsLNaishPF, et al.Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol2001; 12: 1046–1051.
13.
YanHFangWLinA, et al.Three versus 4 daily exchanges and residual kidney function decline in incident CAPD patients: a randomized controlled trial. Am J Kidney Dis2017; 69: 506–513.
14.
JelokaTSanwariaPChaudhariL, et al.‘Ico-Alone’ single nocturnal exchange to initiate peritoneal dialysis in patients with residual renal function – five year, single centre experience. Indian J Nephrol2013; 23: 276–279.
15.
HayatAChoYHawleyC, et al.Association of incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: the balANZ trial. Perit Dial Int. Epub ahead of print 31 May 2023. DOI: 10.1177/08968608231175826.
16.
CheethamMChoYKrishnasamyR, et al.Multicenter registry analysis of incremental peritoneal dialysis incidence and associations with patient outcomes. Perit Dial Int. 2023. DOI: 10.1177/08968608231195517.
17.
JohnsonDWBrownFGClarkeM, et al.Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol2012; 23: 1097–1107.
18.
WangAY-MZhaoJBieberB, et al.International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit Dial Int2020; 40: 310–319.
19.
ManeraKEJohnsonDWCraigJC, et al.Establishing a core outcome set for peritoneal dialysis: report of the SONG-PD (Standardized Outcomes in Nephrology-Peritoneal Dialysis) consensus workshop. Am J Kidney Dis2020; 75: 404–412.
20.
CheethamMSWilkieMLoudF, et al.Establishing a core outcome measure for life participation in patients receiving peritoneal dialysis: a standardised outcomes in Nephrology-Peritoneal Dialysis consensus workshop report. Perit Dial Int2022; 42: 562–570.
